Kevin P. Starr, Director at Sage Therapeutics, Inc. (SAGE), sold 59,000 shares at $169.25 ($10.0M) on 2018-04-17, disclosed to the SEC on 2018-04-19.
Open-market sale of $10.0M SAGE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $169.25 | 35,000 | $5.9M | 59.5% |
| 2 | $168.28 | 24,000 | $4.0M | 40.5% |
| Total | $168.86 avg | 59,000 | $10.0M | 100% |
| Filing → |
| FULC | BUY | 2019-07-22 | $1.3M | — | Filing → |
| MYOK | SELL | 2018-01-05 | $34.3M | — | Filing → |
| MYOK | SELL | 2017-10-04 | $6.1M | — | Filing → |